The Limited Times

Now you can see non-English news...

Study on hydroxychloroquine co-signed by Didier Raoult: the French Medicines Agency will take legal action

2023-06-04T00:01:21.007Z

Highlights: The National Agency for Drug Safety (ANSM) announced that it "is preparing to seize justice" concerning the "pre-print" co-signed by the former director of the IHU of Marseille. The study, published on April 4, has now been removed from the MedRxiv preprint platform. It concerns more than 30,000 patients with Covid-19 treated between March 2, 2020 and December 31, 2021. A judicial investigation had been opened on July 4, 2022 by the Marseille prosecutor's office.


The use of hydroxychloroquine by the professor of the IHU of Marseille "should have benefited from a favorable opinion of a committee for the protection of people and an authorization," says the ANSM.


New twist around Didier Raoult's latest study on hydroxychloroquine. The National Agency for Drug Safety (ANSM) announced that it "is preparing to seize justice" concerning the "pre-print" co-signed by the former director of the IHU of Marseille, published on April 4, now removed from the MedRxiv preprint platform, according to information from Le Parisien confirmed by Franceinfo.

This "pre-print" - a non-peer-reviewed version of a study, published online and not in a scientific journal - had been described earlier this week as "the largest known 'wild' therapeutic trial" by 16 learned societies of medicine in an article published in Le Monde. It concerns more than 30,000 patients with Covid-19 and treated at the IHU of Marseille between March 2, 2020 and December 31, 2021. This study concludes that administration of hydroxychloroquine reduced mortality in these patients. However, according to several scientists, people with heart risk did not receive the treatment, which skews the results.

" READ ALSO Covid-19: Didier Raoult recognizes the effectiveness of the vaccine then denounces a distortion of his words

"Care that saved people"

Moreover, according to the ANSM, the regulations would not have been respected during the clinical trials. "After analysis, we confirm that this study can be qualified as a category 1 IHRP (research involving humans). It should thus have benefited from a favorable opinion of a committee for the protection of persons (CPP) and an authorization (from it) to be implemented, "said the ANSM to the Parisian.

On Twitter, Didier Raoult defended himself by ensuring that the tests would have been a simple "care that saved so many people". "The only guinea pigs are those who have been vaccinated, by an illegal trial due to the lack of consent without coercion. The treated and healed were not guinea pigs but lucky ones!" he added. In the aftermath, Professor Raoult also said that "all the authors" of the study, including him, had finally decided to have it removed from the site. He blames "threats of sanctions".

Read alsoThe risk of fetal malformation increased by taking hydroxychloroquine

A judicial investigation had been opened on July 4, 2022 by the Marseille prosecutor's office, after numerous reports issued by the ANSM in October 2021 and May 2022. For his part, Health Minister François Braun assured Wednesday in the Senate that "justice is taking its course" in this case, while he was questioned on "an inertia of the public authorities" by Senator Bernard Jomier (ecologist, related PS).

Source: lefigaro

All tech articles on 2023-06-04

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.